Technical assistance report no. TA-76-105, TA-76-106 and TA-76-107, Gould, Inc. Kankakee, Illinois, Sherwin, Williams, Coffeyville, Kansas; and N. L. Industries, Fremont, Nebraska.
Authors
Thoburn TW; Carnow BW; Conibear SA
Source
Cincinnati, OH: U.S. Department of Health, Education, and Welfare, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, 1978 Jul; :1-43
Link
NIOSHTIC No.
00114547
Abstract
Medical factors were evaluated between September 29 and November 12, 1976, to determine possible health problems from lead (7439921) exposure at Gould, Incorporated (SIC-3691) Kankakee, Illinois; Sherwin Williams (SIC-2865), Coffeyville, Kansas; and N.L. Industries (SIC-3562), Fremont, Nebraska. The evaluation was requested by OSHA on behalf of 614 exposed employees at the three facilities. Blood lead concentrations of workers in the inorganic chemical facility were normal, while those of other workers were elevated but within the acceptable range of 40 to 60 micrograms per 100 milliliters of whole blood. Workers in the inorganic chemicals facility had abnormally high serum creatinine values but the values were not related to lead exposure. Serum uric-acids were significantly higher than expected and hemoglobins and hematocrits lower than expected, particularly in relation to elevated zinc protoprophyrin determinations. Most values were within the normal range. The investigators note that OSHA time weighted average exposure standard for lead is 0.20 milligrams per cubic meter. They conclude that lead may affect body functions even at blood lead concentrations considered acceptable at the time of the study. They recommend further evaluation of the cause of high serum creatinine values among workers in the inorganic chemicals facility.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.